Trials / Completed
CompletedNCT06686966
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
Clinical Study on the Effect of Preoperative Serum Biomarkers on the Prognosis of Gastric Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,400 (actual)
- Sponsor
- First Affiliated Hospital of Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Gastric cancer is one of the most common cancers worldwide, especially in East Asia. Although surgery remains the main treatment, patients may experience postoperative complications and have varying long-term survival outcomes. Early identification of high-risk patients before surgery is important for improving treatment decisions and patient management. This study aims to develop a prediction model based on routinely available preoperative blood test results and clinical characteristics to estimate the risk of postoperative complications and long-term survival in patients with gastric cancer. The model will be developed and validated using data from multiple medical centers. By using easily accessible clinical information, this study seeks to provide a practical tool to help clinicians better assess patient risk before surgery, support personalized treatment planning, and improve overall patient outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | gastric cancer | be diagnosed as gastric cancer |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2024-11-13
- Last updated
- 2026-03-03
Source: ClinicalTrials.gov record NCT06686966. Inclusion in this directory is not an endorsement.